Please Wait

Applying Filters...

CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

Data Compilation
#PharmaFlow

Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

Stock Recap
#PipelineProspector

Octreotide Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 27 USDMF, 9 CEP/COS, 4 JDMF, 6 EU WC, 1 KDMF, 21 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

240 FDF Dossiers, 61 FDA Orange Book, 92 Europe, 11 Canada, 48 Australia, 8 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML, INJECTABLE;INJECTION - EQ 0.1MG BASE/ML, INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.5MG BASE/ML, INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 2 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 7 Disintegrants & Superdisintegrants, 7 Parenteral, 3 Granulation, 3 Co-Processed Excipients, 1 Topical, 1 API Stability Enhancers, 1 Thickeners and Stabilizers, 1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 39 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 79 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

20 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

4 Others

4 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/07/2025	Bachem AG	Switzerland	BACHEM AG	34145	OCTREOTIDE ACETATE	2019-09-27	Active	II	Complete	2019-11-19	2019-09-19
29/07/2025	TAPI Technology & API Services	Israel	TAPI NL BV	17777	OCTREOTIDE ACETATE	2004-10-21	Active	II	Complete	2015-02-27	2012-11-09

Contact us
to update this info

Octreotide Acetate

Octreotide Acetate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers

27 USDMF

9 CEP/COS

4 JDMF

6 EU WC

1 KDMF

21 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

240 FDF Dossiers

61 FDA Orange Book

92 Europe

11 Canada

48 Australia

8 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

1 Gangwal Healthcare

1 Pfanstiehl

2 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

12 Chewable & Orodispersible Aids

10 Direct Compression

10 Taste Masking

7 Disintegrants & Superdisintegrants

7 Parenteral

3 Granulation

3 Co-Processed Excipients

1 Topical

1 API Stability Enhancers

1 Thickeners and Stabilizers

1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

39 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions

79 Regulatory FDF Prices

11 Annual Reports

MARKET PLACE

20 APIs

16 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents

1 US Exclusivities

REF. STANDARDS & IMPURITIES

4 Others

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons